BioSpace News Archive

Business

Verona Pharma to Report First Quarter 2022 Financial Results and Provide Corporate Update

Verona Pharma plc, a clinical-stage biopharmaceutical company focused on respiratory diseases, announces that it will report its financial results for the three months ended March 31, 2022 on Tuesday, May 3, 2022 and host an investment community conference call at 9:00 a.m. EDT / 2:00 p.m.

April 19, 2022
·
1 min read
Genetown

Biophytis: Biophytis Presents Sarconeos (BIO101) Development Program in Sarcopenia at the 12th Annual International Conference on Frailty and Sarcopenia Research (ICFSR) in Boston April 20-22, 2022

Biophytis SA announces it will present and discuss the results of Sarconeos development program in Sarcopenia at the 12th annual International Conference on Frailty and Sarcopenia Research to be held virtually and on site in Boston from April 20 to April 22, 2022.

April 19, 2022
·
4 min read
Deals

GC Signs Definitive Agreement to Acquire US CDMO BioCentriq, Enhancing Global Capabilities

GC corp. announced that it has signed a definitive agreement to acquire 100% of the shares of BioCentriq, Inc., a pioneering US-based contract development and manufacturing organization that designs and develops scalable cell and gene technologies.

April 19, 2022
·
2 min read
Biotech Beach

Axonics® Announces Comprehensive Launch of the Axonics F15™ Recharge-Free Sacral Neuromodulation System

Axonics, Inc., a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, announced the comprehensive launch of the Axonics F15 across the United States.

April 19, 2022
·
3 min read
Business

Johnson & Johnson Reports Q1 2022 Results

Johnson & Johnson announced results for first-quarter 2022. “Our first quarter results demonstrate strong performance across the enterprise, despite macro-economic headwinds.

April 19, 2022
·
24 min read
Business

Omniose Announces Expanded Leadership Team to Develop Bioconjugate Vaccines Against Serious Bacterial Threats

Omniose announced the expansion of the leadership team to include Timothy Cooke, Ph.D., MBA as Chief Executive Officer and Roman Fleck.

April 19, 2022
·
2 min read
Pharm Country

Humanigen Announces Peer-Reviewed Publication Demonstrating the Potential Clinical and Economic Benefits of Lenzilumab from the Perspective of the NHS

Humanigen, Inc. announced a peer-reviewed publication in ClinicoEconomics and Outcomes Research outlining the potential clinical and health economic benefits of lenzilumab, if authorized or approved for use in the United Kingdom.

April 19, 2022
·
7 min read
Policy

Algenex Announces GMP Certification

Algenex announces that it has received the final audit report from the Spanish Agency for Medicines and Health Products in which they confirm that Algenex complies with the principles of the Good Manufacturing Practices for active substances of the European Union.

April 19, 2022
·
2 min read
Genetown

Moderna Announces Clinical Update on Bivalent COVID-19 Booster Platform

Moderna, Inc. today announced new clinical data on its bivalent COVID-19 booster platform including data on the Company’s first bivalent booster candidate, mRNA-1273.211.

April 19, 2022
·
7 min read
Lone Star Bio

Plus Therapeutics Announces Oral Presentation at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2022 Annual Meeting

Plus Therapeutics, Inc. announced that it will discuss new data in an oral presentation at the Society of Nuclear Medicine and Molecular Imaging 2022 Annual Meeting, being held June 11-14, 2022, in Vancouver, British Columbia, Canada.

April 19, 2022
·
4 min read